Intrauterine Growth Restriction (IUGR)
8
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Determination of Clinical Phenotypes of Intrauterine Growth Restriction in Term Infants Based on Body Composition
Ductus Venosus Doppler in IUGR Pregnancies
Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
Intrauterine Growth Restriction and Intrauterine Fetal Death
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction
Role of Ginkgo Biloba Extract in IUGR